106 related articles for article (PubMed ID: 18693196)
1. Government panel focuses on top priorities for guiding genetic testing policies.
Lavine G
Am J Health Syst Pharm; 2008 Aug; 65(16):1493-4. PubMed ID: 18693196
[No Abstract] [Full Text] [Related]
2. HHS panel examines effects of patents, licenses on genetic testing.
Lavine G
Am J Health Syst Pharm; 2009 Jan; 66(2):114, 116. PubMed ID: 19139472
[No Abstract] [Full Text] [Related]
3. US urged to monitor some genetic tests.
Wadman M
Nature; 1997 Feb; 385(6616):477. PubMed ID: 9020348
[No Abstract] [Full Text] [Related]
4. Government support of genetic services.
Reilly P
Soc Biol; 1978; 25(1):23-32. PubMed ID: 653366
[No Abstract] [Full Text] [Related]
5. Unchecked by government, genetic tests sell hope and hype.
Marris E
Nat Med; 2005 Jun; 11(6):584. PubMed ID: 15937457
[No Abstract] [Full Text] [Related]
6. Re-framing the discussion: commercial genetic testing in Canada.
Williams-Jones B
Health Law J; 1999; 7():49-67. PubMed ID: 11066368
[No Abstract] [Full Text] [Related]
7. Preparing for a consumer-driven genomic age.
Evans JP; Dale DC; Fomous C
N Engl J Med; 2010 Sep; 363(12):1099-103. PubMed ID: 20843241
[No Abstract] [Full Text] [Related]
8. Language ability affects access--HHS issues policy guidance.
Iowa Dent J; 2001 Jan; 87(1):34. PubMed ID: 11935798
[No Abstract] [Full Text] [Related]
9. What's brewing in genetic testing.
Nat Genet; 2002 Dec; 32(4):553-4. PubMed ID: 12457183
[No Abstract] [Full Text] [Related]
10. How regulatory agencies are addressing genetic testing.
Paxton A
CAP Today; 1999 Feb; 13(2):44. PubMed ID: 10346067
[No Abstract] [Full Text] [Related]
11. Genetics services. Inheritance tacks.
Bryan J
Health Serv J; 1999 Apr; 109(5652):20-3. PubMed ID: 10387800
[No Abstract] [Full Text] [Related]
12. Guiding policy decisions for genetic screening: developing a systematic and transparent approach.
Andermann A; Blancquaert I; Beauchamp S; Costea I
Public Health Genomics; 2011; 14(1):9-16. PubMed ID: 20051674
[TBL] [Abstract][Full Text] [Related]
13. Bridging the gap between life insurer and consumer in the genetic testing era: the RF proposal.
Keefer CM
Indiana Law J; 1999; 74(4):1375-95. PubMed ID: 16211754
[No Abstract] [Full Text] [Related]
14. The medical examination in United States immigration applications: the potential use of genetic testing leads to heightened privacy concerns.
Burroughs AM
J Biolaw Bus; 2005; 8(4):22-32. PubMed ID: 16619448
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
[No Abstract] [Full Text] [Related]
16. Medicaid payments and access to care.
Rosenbaum S
N Engl J Med; 2014 Dec; 371(25):2345-7. PubMed ID: 25517705
[No Abstract] [Full Text] [Related]
17. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
18. Molecular medicine: how, what, and when?
Woodcock J
Clin Pharmacol Ther; 2007 Oct; 82(4):376-8. PubMed ID: 17851578
[TBL] [Abstract][Full Text] [Related]
19. The misleading marketing of genetic tests.
Wallace HM
Genewatch; 2005; 18(2):3-5. PubMed ID: 16018109
[No Abstract] [Full Text] [Related]
20. The Institute of Medicine (IOM) report of 2011 and the future of academic dentistry.
Felton DA
J Prosthodont; 2011 Aug; 20(6):427. PubMed ID: 21843227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
